---
title: "Allgens: OssaNova™ artificial bone repair material has obtained registration certification in Vietnam"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249352218.md"
description: "Allgens announced that its OssaNova™ artificial bone repair material has obtained registration certification in Vietnam. This material is based on independently developed intellectual property for in vitro biomimetic mineralization technology and is suitable for bone defect repair in dentistry and orthopedic surgery. The product can be replaced by newly formed bone tissue while guiding bone regeneration, demonstrating good repair capabilities. The acquisition of this registration certification will promote the company's sales in overseas markets and marks an important progress in its overseas business expansion"
datetime: "2025-07-21T07:47:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249352218.md)
  - [en](https://longbridge.com/en/news/249352218.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249352218.md)
---

# Allgens: OssaNova™ artificial bone repair material has obtained registration certification in Vietnam

According to the Zhitong Finance APP, Allgens (688613.SH) announced that the company submitted the registration application materials for its artificial bone repair materials to the Vietnamese Ministry of Health in December 2024. The company recently received notification from the Vietnamese Ministry of Health that its artificial bone repair materials have been approved.

The OssaNova™ artificial bone repair material, which has obtained the registration certificate in Vietnam, is a biomimetic mineralized collagen artificial bone repair material developed and produced based on Allgens' fully independent intellectual property rights in in vitro biomimetic mineralization technology. It is highly biomimetic to human natural bone tissue in terms of composition and microstructure. The product is used for the repair of bone defects in oral or plastic surgery without contraindications for bone grafting. Once implanted, it can guide bone regeneration while being replaced by newly formed bone tissue, making it a medical device product with good bone tissue regeneration and repair capabilities, with broad clinical application potential and market space for various types of bone defect repairs.

The registration certificate obtained for the company's product in Vietnam is an important part of the company's overseas business expansion and will play a certain role in promoting and facilitating the sales of the company's products overseas

### Related Stocks

- [688613.CN](https://longbridge.com/en/quote/688613.CN.md)

## Related News & Research

- [UTG Chairman and CEO Jesse T. Correll buys 4,850 shares for $266,556.00](https://longbridge.com/en/news/287109106.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)
- [Europe-China spacecraft launches to study Earth's 'invisible armour'](https://longbridge.com/en/news/286881963.md)
- [05:54 ETTermHub™ Launches New Managed FHIR Offering for SDOs](https://longbridge.com/en/news/287042225.md)